Healthcare Global Enterprises Share Price
Sector: Healthcare Facilities
374.45 -3.05 (-0.81%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
372.8
Today’s High
379.95
52 Week Low
306.1
52 Week High
401
374.80 -2.90 (-0.77%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
372.25
Today’s High
379.9
52 Week Low
313
52 Week High
401
Key Metrics
- Market Cap (In Cr) 5295.22
- Beta 0.65
- Div. Yield (%) 0
- P/B 6.41
- TTM P/E 97.36
- Peg Ratio 1.11
- Sector P/E 26.87
- D/E 1.54
- Open Price 377.85
- Prev Close 377.5
Healthcare Global Enterprises Analysis
Price Analysis
-
1 Week-0.94%
-
3 Months12.11%
-
6 Month3.39%
-
YTD3.34%
-
1 Year18.61%
Risk Meter
- 30% Low risk
- 30% Moderate risk
- 30% Balanced Risk
- 30% High risk
- 30% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 5
- 5
- 5
- 5
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 6
- 6
- 6
- 6
Healthcare Global Enterprises News
Healthcare Global Enterprises Q4 Results Live : profit rise by 153.73% YOY
1 min read . 01 Jun 2024Healthcare Global Enterprises Q3 FY24 Results Live : Profit Falls by 24.4% YOY
1 min read . 10 Feb 2024Healthcare Global Enterprises Q2 FY24 results: profit rise by 83.88% YOY
1 min read . 12 Nov 2023Healthcare Global Enterprises Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1907.87
- Selling/ General/ Admin Expenses Total
- 308.24
- Depreciation/ Amortization
- 174.36
- Other Operating Expenses Total
- 385.3
- Total Operating Expense
- 1752.99
- Operating Income
- 154.88
- Net Income Before Taxes
- 67.72
- Net Income
- 48.14
- Diluted Normalized EPS
- 3.26
- Period
- 2024
- Total Assets
- 2707.5
- Total Liabilities
- 1881.72
- Total Equity
- 825.78
- Tangible Book Valueper Share Common Eq
- 41.14
- Period
- 2024
- Cashfrom Operating Activities
- 284.58
- Cashfrom Investing Activities
- -225.73
- Cashfrom Financing Activities
- -64.02
- Net Changein Cash
- -5.17
- Period
- 2023
- Total Revenue
- 1691.41
- Selling/ General/ Admin Expenses Total
- 605.86
- Depreciation/ Amortization
- 163.47
- Other Operating Expenses Total
- 8.4
- Total Operating Expense
- 1557.52
- Operating Income
- 133.89
- Net Income Before Taxes
- 44.88
- Net Income
- 29.35
- Diluted Normalized EPS
- 2.14
- Period
- 2023
- Total Assets
- 2316.02
- Total Liabilities
- 1455.5
- Total Equity
- 860.52
- Tangible Book Valueper Share Common Eq
- 47.49
- Period
- 2023
- Cashfrom Operating Activities
- 251.59
- Cashfrom Investing Activities
- -133.03
- Cashfrom Financing Activities
- -140.07
- Net Changein Cash
- -21.51
- Period
- 2022
- Total Revenue
- 1394.78
- Selling/ General/ Admin Expenses Total
- 498.86
- Depreciation/ Amortization
- 158.28
- Other Operating Expenses Total
- 5.64
- Total Operating Expense
- 1222.84
- Operating Income
- 171.93
- Net Income Before Taxes
- 87.77
- Net Income
- 53.73
- Diluted Normalized EPS
- -0.54
- Period
- 2022
- Total Assets
- 2219.52
- Total Liabilities
- 1349.24
- Total Equity
- 870.29
- Tangible Book Valueper Share Common Eq
- 47.42
- Period
- 2022
- Cashfrom Operating Activities
- 220.12
- Cashfrom Investing Activities
- 124.59
- Cashfrom Financing Activities
- -154.88
- Net Changein Cash
- 189.82
- Period
- 2021
- Total Revenue
- 1009.19
- Selling/ General/ Admin Expenses Total
- 415.83
- Depreciation/ Amortization
- 159.22
- Other Operating Expenses Total
- 4.86
- Total Operating Expense
- 1139.47
- Operating Income
- -130.28
- Net Income Before Taxes
- -228.66
- Net Income
- -193.46
- Diluted Normalized EPS
- -11.68
- Period
- 2021
- Total Assets
- 2035.61
- Total Liabilities
- 1338.44
- Total Equity
- 697.18
- Tangible Book Valueper Share Common Eq
- 46.22
- Period
- 2021
- Cashfrom Operating Activities
- 120.52
- Cashfrom Investing Activities
- -171.1
- Cashfrom Financing Activities
- 112.24
- Net Changein Cash
- 61.66
- Period
- 2020
- Total Revenue
- 1092.34
- Selling/ General/ Admin Expenses Total
- 428.7
- Depreciation/ Amortization
- 148.44
- Other Operating Expenses Total
- 4.98
- Total Operating Expense
- 1071.9
- Operating Income
- 20.44
- Net Income Before Taxes
- -119.26
- Net Income
- -106.7
- Diluted Normalized EPS
- -12.05
- Period
- 2020
- Total Assets
- 2253.17
- Total Liabilities
- 1871.92
- Total Equity
- 381.26
- Tangible Book Valueper Share Common Eq
- 27.05
- Period
- 2020
- Cashfrom Operating Activities
- 130.14
- Cashfrom Investing Activities
- -101.38
- Cashfrom Financing Activities
- -58.42
- Net Changein Cash
- -29.67
- Period
- 2019
- Total Revenue
- 976.03
- Selling/ General/ Admin Expenses Total
- 414.67
- Depreciation/ Amortization
- 85.09
- Other Operating Expenses Total
- 5.65
- Total Operating Expense
- 938.48
- Operating Income
- 37.54
- Net Income Before Taxes
- -33.38
- Net Income
- -24.8
- Diluted Normalized EPS
- -2.81
- Period
- 2019
- Total Assets
- 1653.54
- Total Liabilities
- 1176.9
- Total Equity
- 476.65
- Tangible Book Valueper Share Common Eq
- 40.72
- Period
- 2019
- Cashfrom Operating Activities
- 98.5
- Cashfrom Investing Activities
- -238.2
- Cashfrom Financing Activities
- 83.51
- Net Changein Cash
- -56.18
- Period
- 2018
- Total Revenue
- 830.69
- Selling/ General/ Admin Expenses Total
- 340.97
- Depreciation/ Amortization
- 71.46
- Other Operating Expenses Total
- 5.65
- Total Operating Expense
- 772.52
- Operating Income
- 58.17
- Net Income Before Taxes
- 27.18
- Net Income
- 20.52
- Diluted Normalized EPS
- 1.61
- Period
- 2018
- Total Assets
- 1443.66
- Total Liabilities
- 928.56
- Total Equity
- 515.1
- Tangible Book Valueper Share Common Eq
- 46.02
- Period
- 2018
- Cashfrom Operating Activities
- 96.39
- Cashfrom Investing Activities
- -281.7
- Cashfrom Financing Activities
- 161.29
- Net Changein Cash
- -24.02
- Period
- 2024-03-31
- Total Revenue
- 493.25
- Selling/ General/ Admin Expenses Total
- 76.85
- Depreciation/ Amortization
- 45.98
- Other Operating Expenses Total
- 97.41
- Total Operating Expense
- 444.68
- Operating Income
- 48.57
- Net Income Before Taxes
- 28.22
- Net Income
- 21.26
- Diluted Normalized EPS
- 1.28
- Period
- 2024-03-31
- Total Assets
- 2707.5
- Total Liabilities
- 1881.72
- Total Equity
- 825.78
- Tangible Book Valueper Share Common Eq
- 41.14
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 284.58
- Cashfrom Investing Activities
- -225.73
- Cashfrom Financing Activities
- -64.02
- Net Changein Cash
- -5.17
- Period
- 2023-12-31
- Total Revenue
- 468.95
- Selling/ General/ Admin Expenses Total
- 77.33
- Depreciation/ Amortization
- 44.16
- Other Operating Expenses Total
- 95.7
- Total Operating Expense
- 435.41
- Operating Income
- 33.54
- Net Income Before Taxes
- 11.06
- Net Income
- 5.7
- Diluted Normalized EPS
- 0.41
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 485.96
- Selling/ General/ Admin Expenses Total
- 77.16
- Depreciation/ Amortization
- 43.21
- Other Operating Expenses Total
- 98.01
- Total Operating Expense
- 445.52
- Operating Income
- 40.44
- Net Income Before Taxes
- 17.92
- Net Income
- 13.57
- Diluted Normalized EPS
- 0.97
- Period
- 2023-09-30
- Total Assets
- 2418.89
- Total Liabilities
- 1561.12
- Total Equity
- 857.77
- Tangible Book Valueper Share Common Eq
- 46.32
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 63.69
- Cashfrom Investing Activities
- -63.36
- Cashfrom Financing Activities
- -57.37
- Net Changein Cash
- -57.04
- Period
- 2023-06-30
- Total Revenue
- 459.71
- Selling/ General/ Admin Expenses Total
- 76.9
- Depreciation/ Amortization
- 41.01
- Other Operating Expenses Total
- 94.18
- Total Operating Expense
- 427.38
- Operating Income
- 32.33
- Net Income Before Taxes
- 10.52
- Net Income
- 7.61
- Diluted Normalized EPS
- 0.54
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 440.98
- Selling/ General/ Admin Expenses Total
- 68.86
- Depreciation/ Amortization
- 42.2
- Other Operating Expenses Total
- 88.84
- Total Operating Expense
- 407.59
- Operating Income
- 33.39
- Net Income Before Taxes
- 13.14
- Net Income
- 8.38
- Diluted Normalized EPS
- 0.6
- Period
- 2023-03-31
- Total Assets
- 2316.02
- Total Liabilities
- 1455.5
- Total Equity
- 860.52
- Tangible Book Valueper Share Common Eq
- 47.49
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 251.59
- Cashfrom Investing Activities
- -133.03
- Cashfrom Financing Activities
- -140.07
- Net Changein Cash
- -21.51
- Period
- 2022-12-31
- Total Revenue
- 423.91
- Selling/ General/ Admin Expenses Total
- 69.22
- Depreciation/ Amortization
- 40.77
- Other Operating Expenses Total
- 84.08
- Total Operating Expense
- 389.94
- Operating Income
- 33.97
- Net Income Before Taxes
- 11.3
- Net Income
- 7.54
- Diluted Normalized EPS
- 0.54
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Healthcare Global Enterprises Technical
Moving Average
SMA
- 5 Day377.61
- 10 Day381.52
- 20 Day373.57
- 50 Day367.91
- 100 Day361.24
- 300 Day362.58
Healthcare Global Enterprises Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Metropolis Healthcare
- 2014.05
- -40.75
- -1.98
- 2067.7
- 1296
- 10317.74
- Vijaya Diagnostic Centre
- 785.45
- 6.4
- 0.82
- 879.3
- 437.9
- 8038.74
- Healthcare Global Enterprises
- 374.45
- -3.05
- -0.81
- 401
- 306.1
- 5215.7
- Kovai Medical Centre and Hospital
- 4380
- -80.7
- -1.81
- 4777
- 2231.92
- 4792.71
- Thyrocare Technologies
- 654.5
- 3.9
- 0.6
- 722
- 511
- 3464.27
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Metropolis Healthcare
- 77.89
- 9.05
- 20.59
- 14.66
- Vijaya Diagnostic Centre
- 64.17
- 11.73
- 22.14
- 21.2
- Healthcare Global Enterprises
- 113.93
- 6.27
- -4.88
- -3.5
- Kovai Medical Centre and Hospital
- 25.92
- 5.24
- 19.28
- 12.23
- Thyrocare Technologies
- 46.6
- 6.28
- 21.96
- 19.56
Healthcare Global Enterprises Shareholding
Shareholding Pattern
*Promoter pledging: 2.2%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-24
- Audited Results & ESOP
- 08-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results & ESOP
- 25-May-23
- Audited Results
- 09-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- 10-Aug-22
- Quarterly Results
- 26-May-22
- Audited Results
- 10-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Jan-24
- 29-Dec-23
- POM
- 20-Sept-23
- 10-Aug-23
- AGM
- 27-Jun-23
- 29-May-23
- POM
- 08-May-22
- 06-Apr-22
- POM
- 25-May-21
- 26-Apr-21
- POM
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)